Matthieu Martinet

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study

K. Blennow, H. Zetterberg, J. Hugon, 2022, Alzheimer's research & therapy.

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study

K. Blennow, H. Zetterberg, J. Hugon, 2022, Alzheimer's research & therapy.

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice

J. Hugon, C. Paquet, J. Dumurgier, 2022, International journal of molecular sciences.

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib

I. Bièche, E. Raymond, S. Faivre, 2016, Oncotarget.

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

J. Kleeff, V. Paradis, A. Sadanandam, 2019, The Journal of pathology.

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study

K. Blennow, H. Zetterberg, J. Hugon, 2022, Neurobiology of Disease.

Abstract 3000: Angiogenic recovery under chronic exposure to sunitinib is associated with vasculogenic mimicry in renal cell carcinoma

E. Raymond, S. Faivre, M. Serova, 2014 .

Abstract B175: TGF-β-RI kinase inhibitors LY2157299 and LY364947 decrease motility and invasion in hepatocarcinoma (HCC) cells developing resistance to VEGFR/PDGFR kinase inhibitors.

I. Bièche, E. Raymond, S. Faivre, 2011 .

Plasma leptin is associated with amyloid CSF biomarkers and Alzheimer's disease diagnosis in cognitively impaired patients.

J. Hugon, C. Paquet, J. Dumurgier, 2022, The journals of gerontology. Series A, Biological sciences and medical sciences.

Response to the Comment on "Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients".

J. Hugon, C. Paquet, J. Dumurgier, 2023, The journals of gerontology. Series A, Biological sciences and medical sciences.